Hormonal regulation of serum lipoprotein(a) levels: Contrasting effects of growth hormone and insulin-like growth factor-I

Hans Olivecrona, Anna G. Johansson, Erik Lindh, Sverker Ljunghall, Lars Berglund, Bo Angelin

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

In response to treatment with growth hormone, serum levels of lipoprotein(a) increase, while those of LDL cholesterol decrease. To establish if increased levels of insulin-like growth factor-I may be of importance for these changes, we analyzed serum lipoprotein concentrations in II male patients with idiopathic osteoporosis who were treated with growth hormone (2 IU · m-2 · d-1) or insulin-like growth factor-I (80 μg · kg-1 · d-1) in a randomized, double-blind, cross-over study. LDL cholesterol was reduced by 0.7 mmol/L (P<.01) during growth hormone treatment but was not affected when the same patients received insulin-like growth factor-I. In contrast, mean lipoprotein(a) levels increased from 519 to 571 mg/L (P<.03) in response to growth hormone but were reduced from 538 to 478 mg/L (P<.04) during treatment with insulin-like growth factor-I. These results indicate that growth hormone exerts its effects on lipoprotein metabolism independent of insulin-like growth factor-I. Furthermore, the results suggest that treatment with insulin-like growth factor-I may reduce lipoprotein(a) levels.

Original languageEnglish (US)
Pages (from-to)847-849
Number of pages3
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume15
Issue number7
StatePublished - Jul 1995
Externally publishedYes

Fingerprint

Lipoprotein(a)
Insulin-Like Growth Factor I
Growth Hormone
Serum
LDL Cholesterol
Lipoproteins
Therapeutics
Cross-Over Studies
Osteoporosis

Keywords

  • growth hormone
  • insulin-like growth factor-I
  • lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hormonal regulation of serum lipoprotein(a) levels : Contrasting effects of growth hormone and insulin-like growth factor-I. / Olivecrona, Hans; Johansson, Anna G.; Lindh, Erik; Ljunghall, Sverker; Berglund, Lars; Angelin, Bo.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 15, No. 7, 07.1995, p. 847-849.

Research output: Contribution to journalArticle

Olivecrona, Hans ; Johansson, Anna G. ; Lindh, Erik ; Ljunghall, Sverker ; Berglund, Lars ; Angelin, Bo. / Hormonal regulation of serum lipoprotein(a) levels : Contrasting effects of growth hormone and insulin-like growth factor-I. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1995 ; Vol. 15, No. 7. pp. 847-849.
@article{0e2810798a8f4aedad98ed459fbc7596,
title = "Hormonal regulation of serum lipoprotein(a) levels: Contrasting effects of growth hormone and insulin-like growth factor-I",
abstract = "In response to treatment with growth hormone, serum levels of lipoprotein(a) increase, while those of LDL cholesterol decrease. To establish if increased levels of insulin-like growth factor-I may be of importance for these changes, we analyzed serum lipoprotein concentrations in II male patients with idiopathic osteoporosis who were treated with growth hormone (2 IU · m-2 · d-1) or insulin-like growth factor-I (80 μg · kg-1 · d-1) in a randomized, double-blind, cross-over study. LDL cholesterol was reduced by 0.7 mmol/L (P<.01) during growth hormone treatment but was not affected when the same patients received insulin-like growth factor-I. In contrast, mean lipoprotein(a) levels increased from 519 to 571 mg/L (P<.03) in response to growth hormone but were reduced from 538 to 478 mg/L (P<.04) during treatment with insulin-like growth factor-I. These results indicate that growth hormone exerts its effects on lipoprotein metabolism independent of insulin-like growth factor-I. Furthermore, the results suggest that treatment with insulin-like growth factor-I may reduce lipoprotein(a) levels.",
keywords = "growth hormone, insulin-like growth factor-I, lipoprotein",
author = "Hans Olivecrona and Johansson, {Anna G.} and Erik Lindh and Sverker Ljunghall and Lars Berglund and Bo Angelin",
year = "1995",
month = "7",
language = "English (US)",
volume = "15",
pages = "847--849",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Hormonal regulation of serum lipoprotein(a) levels

T2 - Contrasting effects of growth hormone and insulin-like growth factor-I

AU - Olivecrona, Hans

AU - Johansson, Anna G.

AU - Lindh, Erik

AU - Ljunghall, Sverker

AU - Berglund, Lars

AU - Angelin, Bo

PY - 1995/7

Y1 - 1995/7

N2 - In response to treatment with growth hormone, serum levels of lipoprotein(a) increase, while those of LDL cholesterol decrease. To establish if increased levels of insulin-like growth factor-I may be of importance for these changes, we analyzed serum lipoprotein concentrations in II male patients with idiopathic osteoporosis who were treated with growth hormone (2 IU · m-2 · d-1) or insulin-like growth factor-I (80 μg · kg-1 · d-1) in a randomized, double-blind, cross-over study. LDL cholesterol was reduced by 0.7 mmol/L (P<.01) during growth hormone treatment but was not affected when the same patients received insulin-like growth factor-I. In contrast, mean lipoprotein(a) levels increased from 519 to 571 mg/L (P<.03) in response to growth hormone but were reduced from 538 to 478 mg/L (P<.04) during treatment with insulin-like growth factor-I. These results indicate that growth hormone exerts its effects on lipoprotein metabolism independent of insulin-like growth factor-I. Furthermore, the results suggest that treatment with insulin-like growth factor-I may reduce lipoprotein(a) levels.

AB - In response to treatment with growth hormone, serum levels of lipoprotein(a) increase, while those of LDL cholesterol decrease. To establish if increased levels of insulin-like growth factor-I may be of importance for these changes, we analyzed serum lipoprotein concentrations in II male patients with idiopathic osteoporosis who were treated with growth hormone (2 IU · m-2 · d-1) or insulin-like growth factor-I (80 μg · kg-1 · d-1) in a randomized, double-blind, cross-over study. LDL cholesterol was reduced by 0.7 mmol/L (P<.01) during growth hormone treatment but was not affected when the same patients received insulin-like growth factor-I. In contrast, mean lipoprotein(a) levels increased from 519 to 571 mg/L (P<.03) in response to growth hormone but were reduced from 538 to 478 mg/L (P<.04) during treatment with insulin-like growth factor-I. These results indicate that growth hormone exerts its effects on lipoprotein metabolism independent of insulin-like growth factor-I. Furthermore, the results suggest that treatment with insulin-like growth factor-I may reduce lipoprotein(a) levels.

KW - growth hormone

KW - insulin-like growth factor-I

KW - lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=0029074250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029074250&partnerID=8YFLogxK

M3 - Article

C2 - 7600115

AN - SCOPUS:0029074250

VL - 15

SP - 847

EP - 849

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -